top of page
Robin Smith
Original Visionary/Founder
Robin Smith is a scientist, biotech leader, and multi-exit entrepreneur with more than 25 years of experience building companies across life sciences, diagnostics, laboratory informatics, software, and biotechnology. His entrepreneurial history includes founding and leading companies such as Synthematix and ArtusLabs and advancing technologies from early development through commercialization and acquisition.
At WonderBank, Robin leads the development of its iPSC platform and regenerative-medicine initiatives, including applications in scalable allogeneic cell therapy, neurological disease modeling, drug discovery, and next-generation therapeutic development.
Eric von Hofe, PhD
Co-Founder
Eric von Hofe, PhD, is a biotechnology executive and scientific leader with more than 30 years of experience advancing innovative therapeutic technologies from research through clinical development.
His career spans cell therapy, immunotherapy, personalized medicine, translational research, and drug development. Dr. von Hofe has held leadership roles at AffyImmune Therapeutics, Antigen Express, and Millennium Pharmaceuticals, where he helped advance novel therapeutic programs, build strategic industry collaborations, and guide emerging technologies toward clinical application.
Ruvin Orbach
Co-Founder
Ruvin Orbach is a biotechnology entrepreneur, investor, and business leader with experience building and supporting companies focused on advanced therapeutics, regenerative medicine, and cell-based technologies.
His work spans company formation, strategic partnerships, financing, commercialization, and business development across emerging healthcare ventures. He has been involved in advancing platforms and companies focused on oncology, regenerative medicine, cell therapy, and other areas of significant unmet medical need.
bottom of page